In IBD patients, Th17 becomes dominant and Treg declines, so that inflammatory cytokines, TNF-α, and interferon-γ (IFN-γ) increase, and an anti-inflammatory cytokine transforming growth factor-β (TGF-β) decreases [15]. Here, TGFB1 is linked to inflammatory bowel disease.